Birtamimab |
カタログ番号GC72393 |
Birtamimab(NEOD 001)は、アミロイドを特異的かつ選択的に標的化し、除去する研究モノクローナル抗体である。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1608108-91-3
Sample solution is provided at 25 µL, 10mM.
Birtamimab can neutralize circulating soluble amyloid and deposited insoluble amyloid, thus promoting the phagocytic clearance of amyloid deposits[1].
References:
[1]. AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *